4 days ago
DOH suspends new fees for registration of health products
The Food and Drug Administration (FDA) on Thursday called on the Department of Health (DOH) to approve the immediate suspension of increased fees for facility registration and certificate of product registration for health products.
The Department of Health (DOH) suspended the implementation of adjusted regulatory fees and charges for facility registration and Certificates of Product Registration (CPR) for health products.
In an advisory, Health Secretary Teodoro Herbosa announced the 60-day suspension of Administrative Order No. 2024-0016, which contains the details of the adjusted fees.
The FDA earlier sought a temporary halt to the order "to assess certain provisions of the AO in coordination with the FDA's concerned centers."
The recommendation was made in line with President Ferdinand Marcos Jr.'s directives to ease the burden on businesses and improve access to medicine.
According to an earlier statement, FDA said it would continue to advocate for a 'fair, transparent, and aligned' efforts for healthcare regulation.
FDA Director General Paolo Teston noted that any increase in regulatory fees must be supported by visible improvements in service delivery and operational efficiency.
'Mahigpit ngayong nagtutulungan ang DOH at FDA sa mga kinauukulang partido upang matiyak na ang anumang binago o bagong bayarin ay kinakailangan,' DOH said.
(The DOH and FDA are closely coordinating with concerned parties to ensure any changes or adjusted fees are needed.) —Jiselle Anne Casucian/LDF, GMA Integrated News
